Company intelligence / Profile preview
Trevarx Biomedical
Philadelphia, Pennsylvania, United Statesmembers.lifesciencespa.org ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Trevarx Biomedical is advancing two main programs. [18F]FluorThanatrace ([18F]FTT), a PET imaging biomarker for PARP1 expression, is in Phase 2 multicenter trials in breast cancer with over 296 patients imaged and no adverse events reported. The second program, [211At]PTT, an alpha-emitting therapeutic targeting PARP1, has shown strong preclinical efficacy in neuroblastoma models and is preparing for Phase 1 trials in ovarian cancer. The company’s dual diagnostic/therapeutic approach enables precision oncology by matching patients to appropriate therapies based on real-time tumor biology.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeDiagnostic radiopharmaceuticalsTherapeutic radiopharmaceuticals
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
MD Anderson Cancer CenterUniversity of PennsylvaniaWashington University at St. LouisUniversity of Washington
Beyond the preview
Go deeper on Trevarx Biomedical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trevarx Biomedical.